Cargando…
Neuronal human BACE1 knockin induces systemic diabetes in mice
AIMS: β-Secretase 1 (BACE1) is a key enzyme in Alzheimer’s disease pathogenesis that catalyses the amyloidogenic cleavage of amyloid precursor protein (APP). Recently, global Bace1 deletion was shown to protect against diet-induced obesity and diabetes, suggesting that BACE1 is a potential regulator...
Autores principales: | Plucińska, Kaja, Dekeryte, Ruta, Koss, David, Shearer, Kirsty, Mody, Nimesh, Whitfield, Phillip D., Doherty, Mary K., Mingarelli, Marco, Welch, Andy, Riedel, Gernot, Delibegovic, Mirela, Platt, Bettina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4901117/ https://www.ncbi.nlm.nih.gov/pubmed/27138913 http://dx.doi.org/10.1007/s00125-016-3960-1 |
Ejemplares similares
-
Knock-in of Mutated hTAU Causes Insulin Resistance, Inflammation and Proteostasis Disturbance in a Mouse Model of Frontotemporal Dementia
por: Hull, Claire, et al.
Publicado: (2019) -
Fenretinide inhibits obesity and fatty liver disease but induces Smpd3 to increase serum ceramides and worsen atherosclerosis in LDLR(−/−) mice
por: Thompson, Dawn, et al.
Publicado: (2023) -
Myeloid PTP1B deficiency protects against atherosclerosis by improving cholesterol homeostasis through an AMPK-dependent mechanism
por: Oliver, Helk, et al.
Publicado: (2023) -
Elevated Fibroblast growth factor 21 (FGF21) in obese, insulin resistant states is normalised by the synthetic retinoid Fenretinide in mice
por: Morrice, Nicola, et al.
Publicado: (2017) -
Fenretinide Treatment Prevents Diet-Induced Obesity in Association With Major Alterations in Retinoid Homeostatic Gene Expression in Adipose, Liver, and Hypothalamus
por: Mcilroy, George D., et al.
Publicado: (2013)